Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction

Author(s):
Verschuren, J.J.W.; Boden, H.; Wessels, J.A.M.; Hoeven, B.L. van der; Trompet, S.; Heijmans, B.T. (0000-0001-5918-0534); Putter, H.; Guchelaar, H.J. (0000-0002-7085-1383); Schalij, M.J.; Jukema, J.W. (0000-0002-3246-8359)
Published
2013
Publication type
Article / Letter to editor
PharmacogeneticsAntiplatelet therapyST-segment elevation myocardial infarctionTreatment outcomeCytochrome P450 2C19Cyclooxygenase 1
Date issued
2013-09-10
Language
English
Is part of
International Journal of Cardiology (2013), Vol. 167, no. 6, p. 2882-2888
hdl
1887/103931
doi
10.1016/j.ijcard.2012.07.020